Importer of Controlled Substances Application: Almac Clinical Services Incorp. (ACSI), 28384 [2021-11069]
Download as PDF
<![CDATA[
28384
Federal Register / Vol. 86, No. 100 / Wednesday, May 26, 2021 / Notices
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on May 6, 2021, Purisys,
LLC, 1550 Olympic Drive, Atlanta,
Georgia 30601–1602, applied to be
registered as an importer of the
following basic class(es) of controlled
substance(s):
Controlled substance
Noroxymorphone ..........
Drug
code
Schedule
9668
II
The company plans to use as
reference standards for analytical and
research purposes for their customers.
No other activity for this drug code is
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–11070 Filed 5–25–21; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
issuance of the proposed registration on
or before June 25, 2021. Such persons
may also file a written request for a
hearing on the application on or before
June 25, 2021.
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on April 30, 2021, Almac
Clinical Services Incorp, (ACSI) 25 Fretz
Road, Souderton, Pennsylvania 18964,
applied to be registered as an importer
of the following basic class(es) of
controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Psilocybin .....................
Oxycodone ...................
Hydromorphone ............
Morphine .......................
Noroxymorphone ..........
Tapentadol ....................
Fentanyl ........................
Drug
code
7437
9143
9150
9330
9668
9780
9801
[Docket No. DEA–840]
Importer of Controlled Substances
Application: Almac Clinical Services
Incorp. (ACSI)
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Almac Clinical Services
Incorp. (ACSI) has applied to be
registered as an importer of basic
class(es) of controlled substance(s).
Refer to Supplementary Information
listed below for further drug
information.
SUMMARY:
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–11069 Filed 5–25–21; 8:45 am]
BILLING CODE P
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
DATES:
20:00 May 25, 2021
Jkt 253001
I
II
II
II
II
II
II
The company plans to import the
listed finished dosage unit products
controlled substances in dosage form to
conduct clinical trials. Approval of
permit applications will occur only
when the registrant’s business activity is
consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization
will not extend to import of the Food
and Drug Administration-approved or
non-approved finished dosage forms for
commercial sale.
Drug Enforcement Administration
VerDate Sep<11>2014
Schedule
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
DEPARTMENT OF LABOR
Employment and Training
Administration
Workforce Innovation and Opportunity
Act; Native American Employment and
Training Council
Employment and Training
Administration, U.S. Department of
Labor.
ACTION: Notice of meeting.
AGENCY:
Pursuant to the Federal
Advisory Committee Act (FACA), and
the Workforce Innovation and
Opportunity Act (WIOA), notice is
hereby given of the next meeting of the
Native American Employment and
Training Council (Council), as
constituted under WIOA.
DATES: The meeting will begin at 12:00
p.m., (Eastern Daylight Time) on
Tuesday, June 15, 2021, and continue
until 4:30 p.m. The meeting will
reconvene at 12:00 p.m., on Wednesday,
June 16, 2021 and adjourn at 4:30 p.m.
The period from 3:00 p.m., to 4:00 p.m.,
on June 16, 2021 is reserved for
participation and comment by members
of the public.
ADDRESSES: The meeting will be held
virtually on the Zoom.gov platform. To
join the meeting use the following:
https://www.zoomgov.com/j/
1613101548?pwd=dDBXQk1Uc2ht
NGZYR08rQ0s4VXB5QT09.
Meeting ID: 161 310 1548.
Passcode: 513970.
Dial in number: +1 (551) 285–1373.
SUPPLEMENTARY INFORMATION: Council
members and members of the public are
encouraged to logon to Zoom.gov early
to allow for connection issues and
troubleshooting.
Security Instructions: Meeting
participants should use the link and dial
in instructions provided in ADDRESSES.
The meeting will be open to the
public.
Members of the public not present
may submit a written statement by
Thursday, June 11, 2021, to be included
in the record of the meeting. Statements
are to be submitted to Athena R. Brown,
Designated Federal Officer (DFO), U.S.
Department of Labor at brown.athena@
dol.gov. Persons who need special
accommodations should contact Suzie
Casal at (703) 967–1829 or casal.suzie@
dol.gov, at least two business days
before the meeting. The formal agenda
will focus on the following topics: (1)
Update of National Congress of
American Indians policy
recommendations, (2) PY 2021/2022
training and technical assistance
priorities, (3) update on Indian and
SUMMARY:
E:\FR\FM\26MYN1.SGM
26MYN1
]]>Agencies
[Federal Register Volume 86, Number 100 (Wednesday, May 26, 2021)]
[Notices]
[Page 28384]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-11069]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-840]
Importer of Controlled Substances Application: Almac Clinical
Services Incorp. (ACSI)
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Almac Clinical Services Incorp. (ACSI) has applied to be
registered as an importer of basic class(es) of controlled
substance(s). Refer to Supplementary Information listed below for
further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before June 25, 2021.
Such persons may also file a written request for a hearing on the
application on or before June 25, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
request for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on April 30, 2021, Almac Clinical Services Incorp,
(ACSI) 25 Fretz Road, Souderton, Pennsylvania 18964, applied to be
registered as an importer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Psilocybin............................. 7437 I
Oxycodone.............................. 9143 II
Hydromorphone.......................... 9150 II
Morphine............................... 9330 II
Noroxymorphone......................... 9668 II
Tapentadol............................. 9780 II
Fentanyl............................... 9801 II
------------------------------------------------------------------------
The company plans to import the listed finished dosage unit
products controlled substances in dosage form to conduct clinical
trials. Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to import of
the Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-11069 Filed 5-25-21; 8:45 am]
BILLING CODE P
